Skip to content

Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain

Effects of Bodily Illusion and tDCS on Spinal Cord Injury (SCI) Related Neuropathic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04578574
Enrollment
8
Registered
2020-10-08
Start date
2021-01-13
Completion date
2023-03-10
Last updated
2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain

Brief summary

The purpose of this study is to evaluate the effect of a combination of two procedures: (1) Bodily Illusion (BI) and (2) Transcranial direct electrical stimulation (tDCS) on neuropathic pain.

Interventions

OTHERBodily Illusions (BI) Procedure

Each sessions will consists of two types of illusions that are 15 min each, the rubber hand illusion (RHI) and the walking illusion (WI) that involve both arms and legs.

DEVICETranscranial direct electrical stimulation (tDCS)

Each sessions will consists of electrical current delivered from a battery-driven, constant current stimulator using saline-soaked surface sponge electrodes. One electrode will be placed on your scalp on the right side and the other electrode over the left eye on your forehead. A weak current will be applied for 30 min at the same time as the BI.

OTHERSham Transcranial Direct Electrical Stimulation (tDCS)

Each session of the Sham tDCS will be applied for 30 min at the same time as the BI.

Sponsors

Florida
CollaboratorOTHER
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Participants will be men or women, 18-70 years of age, with an incomplete cervical traumatic SCI. 2. Participants must have experienced neuropathic pain for a minimum of six months. They must have neuropathic pain in the moderate to severe category, which will be defined as a score of at least 4 on a Numeric Rating Scale (NRS); (range of 0 to 10). 3. Participants must be willing and able to sign informed consent

Exclusion criteria

1. Major psychiatric disease/disorder (self-reported) 2. A significant neurological trauma besides SCI 3. A recent (one-year) history of alcohol or drug abuse (selfreported) 4. Any other medical conditions in which transcranial DCS is relatively contraindicated, such as pregnancy, epilepsy and/or seizures

Design outcomes

Primary

MeasureTime frameDescription
Change in Neuropathic Pain Severitybaseline, up to two weeksAssessed by the use of the Neuropathic Pain Symptom Inventory (NPSI). The NPSI has a total score ranging from 0 to 100 with the higher score indicating greater pain.
Change in Performance of Body Part Processingbaseline, up to two weeksAssessed by a customized computer task, where individual reaction times will be measured in response to mental rotation of body parts. Results will be reported in milliseconds.

Secondary

MeasureTime frameDescription
Change in Sensory Thresholdsbaseline, up to two weeksAssessed by the Quantitative Sensory Testing. Pain thresholds are evaluated using Medoc machine (Medoc Ltd,Ramat Yishai, Israel and FDA approved. It assesses participants' ability to feel change in temperature (0°C to 50°C). The temperatures in this range may be felt as cool, cold, warm, and hot. A probe is placed on the skin and it feels either cool, cold, warm or hot. Participants' thresholds are recorded for cool or warm sensation, and for cold or hot painful thresholds.

Countries

United States

Participant flow

Participants by arm

ArmCount
BI-TDCS Stimulation Group
Participants in this group will receive the BI and TDCS interventions for 10 sessions over two weeks. Bodily Illusions (BI) Procedure: Each sessions will consists of two types of illusions that are 15 min each, the rubber hand illusion (RHI) and the walking illusion (WI) that involve both arms and legs. Transcranial direct electrical stimulation (tDCS): Each sessions will consists of electrical current delivered from a battery-driven, constant current stimulator using saline-soaked surface sponge electrodes. One electrode will be placed on your scalp on the right side and the other electrode over the left eye on your forehead. A weak current will be applied for 30 min at the same time as the BI.
6
BI-TDCS (Sham) Stimulation Group
Participants in this group will receive the BI and TDCS (Sham) interventions for 10 sessions over two weeks. Bodily Illusions (BI) Procedure: Each sessions will consists of two types of illusions that are 15 min each, the rubber hand illusion (RHI) and the walking illusion (WI) that involve both arms and legs. Sham Transcranial Direct Electrical Stimulation (tDCS): Each session of the Sham tDCS will be applied for 30 min at the same time as the BI.
2
Total8

Baseline characteristics

CharacteristicBI-TDCS Stimulation GroupBI-TDCS (Sham) Stimulation GroupTotal
Age, Continuous50 years
STANDARD_DEVIATION 16
40 years
STANDARD_DEVIATION 7
48 years
STANDARD_DEVIATION 14.9
Race/Ethnicity, Customized
Black American
0 Participants2 Participants2 Participants
Race/Ethnicity, Customized
Hispanic or Latino
3 Participants0 Participants3 Participants
Race/Ethnicity, Customized
White
3 Participants0 Participants3 Participants
Region of Enrollment
South America
1 participants0 participants1 participants
Region of Enrollment
United States
5 participants2 participants7 participants
Sex: Female, Male
Female
2 Participants0 Participants2 Participants
Sex: Female, Male
Male
4 Participants2 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 2
other
Total, other adverse events
0 / 60 / 2
serious
Total, serious adverse events
0 / 60 / 2

Outcome results

Primary

Change in Neuropathic Pain Severity

Assessed by the use of the Neuropathic Pain Symptom Inventory (NPSI). The NPSI has a total score ranging from 0 to 100 with the higher score indicating greater pain.

Time frame: baseline, up to two weeks

ArmMeasureValue (MEAN)Dispersion
BI-TDCS Stimulation GroupChange in Neuropathic Pain Severity-7.3 score on a scaleStandard Deviation 3.9
BI-TDCS (Sham) Stimulation GroupChange in Neuropathic Pain Severity8.5 score on a scaleStandard Deviation 6.3
Primary

Change in Performance of Body Part Processing

Assessed by a customized computer task, where individual reaction times will be measured in response to mental rotation of body parts. Results will be reported in milliseconds.

Time frame: baseline, up to two weeks

ArmMeasureGroupValue (MEAN)Dispersion
BI-TDCS Stimulation GroupChange in Performance of Body Part Processingchange scores in mental rotation of body parts-18.2 milliseconds (reaction times)Standard Deviation 67.5
BI-TDCS Stimulation GroupChange in Performance of Body Part Processingchange scores in mental rotation of control stimuli-4.5 milliseconds (reaction times)Standard Deviation 92
BI-TDCS (Sham) Stimulation GroupChange in Performance of Body Part Processingchange scores in mental rotation of body parts30.9 milliseconds (reaction times)Standard Deviation 25
BI-TDCS (Sham) Stimulation GroupChange in Performance of Body Part Processingchange scores in mental rotation of control stimuli4.4 milliseconds (reaction times)Standard Deviation 54
Secondary

Change in Sensory Thresholds

Assessed by the Quantitative Sensory Testing. Pain thresholds are evaluated using Medoc machine (Medoc Ltd,Ramat Yishai, Israel and FDA approved. It assesses participants' ability to feel change in temperature (0°C to 50°C). The temperatures in this range may be felt as cool, cold, warm, and hot. A probe is placed on the skin and it feels either cool, cold, warm or hot. Participants' thresholds are recorded for cool or warm sensation, and for cold or hot painful thresholds.

Time frame: baseline, up to two weeks

ArmMeasureGroupValue (MEAN)Dispersion
BI-TDCS Stimulation GroupChange in Sensory Thresholdsdelta pain threshold and perception threshold of painful site expressed as change score (hot-warm)2.2 CelsiusStandard Deviation 6.5
BI-TDCS Stimulation GroupChange in Sensory Thresholdsdelta pain thresh. and perception threshold of painful site expressed as change score (cold-cool)-1.37 CelsiusStandard Deviation 5.4
BI-TDCS (Sham) Stimulation GroupChange in Sensory Thresholdsdelta pain threshold and perception threshold of painful site expressed as change score (hot-warm)-1.3 CelsiusStandard Deviation 4
BI-TDCS (Sham) Stimulation GroupChange in Sensory Thresholdsdelta pain thresh. and perception threshold of painful site expressed as change score (cold-cool)3.9 CelsiusStandard Deviation 1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026